Key result
Performing coronary angiography 24 to 72 hours versus after 72 hours following successful fibrinolytic therapy in STEMI patients resulted in no significant difference in long-term major adverse cardiac events.
Why the study?
The study aimed to compare outcomes of STEMI patients receiving successful fibrinolytic therapy who underwent coronary angiography within 24 to 72 hours versus after 72 hours.
Does coronary angiography within 24-72 hours compared to >72 hours reduce MACE in STEMI patients after successful fibrinolytic therapy?
Observational (n=76)
No
Does coronary angiography within 24-72 hours compared to >72 hours reduce MACE in STEMI patients after successful fibrinolytic therapy?
Performing coronary angiography within 24-72 hours versus after 72 hours following successful fibrinolytic therapy for STEMI did not significantly affect short- or long-term MACE rates.
Answers are grounded in this paper and cite their sources.
No difference in MACE by CAG timing after 24 h; leaves open optimal post-fibrinolysis angiography window in STEMI.
BACKGROUND: We aimed to compare outcomes of patients received successful fibrinolytic treatment (FT) for ST-segment elevated myocardial infarction (STEMI) and performed coronary angiography (CAG) within 24 - 72 h or after 72 h. METHODS: Between March 2013 and November 2014, 76 STEMI patients received successful FT and performed CAG > 24 h were included in the study. Patients were divided into two groups according to the time-interval from FT admission to CAG performing (Group-1, 24 - 72 h (n = 29), Group-2, > 72 h (n = 47)). The primary end point was major adverse cardiac events (MACE) defined as cardiovascular death, non-fatal myocardial infarction, and heart failure. RESULTS: The mean age of patients were 56 ± 11.4 years old (27.6% female). CAG was performed within mean 2.17 ± 0.38 days in the Group-1 and 2.9 ± 11.5 days in the Group 2 (P < 0.001). At short-term follow-up (6 months), MACE rate was higher in Group-2 (21.3%) than Group-1(13.8%), but it was not statistically significant (P = 0.661). The rate of MACE was 37.9% in Group-1 and 38.3% in Group-2 (P = 0.974) in the long-term follow-up (median: 57 months). Overall cardiac mortality rate was 7.9%, the re-infarction rate was 19.7% and heart failure was 17.1% in long-term follow-up, and there were no significant difference between groups. CONCLUSIONS: Present study has shown that performance of CAG after 24 h of successful FT, within 24 - 74 h or > 72 h, did not shown any difference in term of MACE both in short and long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Kılıç et al. (2019) conducted an observational in ST-segment elevated myocardial infarction (STEMI) (n=76). Coronary angiography within 24-72 hours vs. Coronary angiography after 72 hours was evaluated on Major adverse cardiac events (MACE) defined as cardiovascular death, non-fatal myocardial infarction, and heart failure at long-term follow-up (p=0.974). Performing coronary angiography 24 to 72 hours versus after 72 hours following successful fibrinolytic therapy in STEMI patients resulted in no significant difference in long-term major adverse cardiac events.
Synapse has enriched 10 related papers. Consider them for comparative context: